Indications and uses
For relieving muscle strains and soreness from working out
For relieving muscle strains and soreness from working out
Bath- Soaking Aid Dissolve 2 cups into a tub of hot water and soak for 15-30 minutes. Foot or Wrist Soak Dissolve 2 cups into a foot-soaking tub half-full of water, soaking the injured area for 20-30 minutes. Repeat 2-3 times per day until relief is obtained.
Magnesium Sulfate U.S.P. 100% (Epsom salt)
Soaking Solution
For relieving muscle strains and soreness from working out
For external use only
If swallowed, get medical help or contact a Poison Control Center right away.
Bath- Soaking Aid
Dissolve 2 cups into a tub of hot water and soak for 15-30 minutes.
Foot or Wrist Soak
Dissolve 2 cups into a foot-soaking tub half-full of water, soaking the injured area for 20-30 minutes. Repeat 2-3 times per day until relief is obtained.
Silicon dioxide, sodium copper chlorophyllin, spearmint.
1-877-FEEL-PEP

SOAKING AID FOR RELIEF OF PAIN AND SORE MUSCLES
BLENDED WITH 100% NATURAL MINERAL+ MINT
NEW SOAKING AID
RESEALABLE POUCH CUT ALONG DOTTED LINE
PEPSOM SPORTS®
THE ORIGINAL SPORT SOAKTM
MAGNESIUM SULFATE U.S.P. + MINT
FIRE ICE FORMULA
SPEARMINT
SOAKING AID FOR RELIEF OF
Pain • Sore Muscles • Minor Sprains • Bruises
NBATA ENDORSED
NATIONAL BASKETBALL ATHLETIC TRAINERS ASSOCIATIONTM
NET WT. 48 OZ. (3 lbs.) 1.36 kg
RESEALABLE POUCH CUT ALONG DOTTED LINE
PEPSOM SPORTS®
MAGNESIUM SULFATE U.S.P. + MINT
THE ORIGINAL SPORT SOAKTM
SPEARMINT
ENDORSED BY
NATIONAL BASKETBALL ATHLETIC TRAINERS ASSOCIATIONTM
The NBATA Mark is a trademark of the NBATA and is being used by
The Pepsom Group, Inc. under license from NBATA
A NEW PRODUCT created for athletes and "Weekend Warriors" of all ages!
PEPSOM SPORTS® is a blend of 100% NATURAL INGREDIENTS that help to reduce Sport-related and other minor aches and pains, bruises and strains. EVEN IF YOU HAVE NO SORENESS OR PAIN, YOU WILL LOVE PEPSOM SPORTS®, THE ORIGINAL SPORT SOAK™.
ENDORSED BY the NBATA™
National Basketball Athletic Trainers Association™
FIRE ICE FORMULA
Combining the "FIRE" of HYDROTHERAPY (treatment for injury with water) to SOAK AWAY PAIN together with the cooling "ICE" sensation of MINT to REFRESH EVERY MUSCLE.
PEPSOM SPORTS® "FIRE★ICE" Formula combines an age-old remedy with some of the ingredients used for decades by some of the TOP ATHLETIC TRAINERS of the sporting world....special formulations that they've been using to ease sore muscles, pain, soreness, bruises and muscle pulls.
WHEN TO USE
BEFORE WORKOUT/GAME: Soaking in a very warm bath with PEPSOM SPORTS® can help relax your muscles and get you ready for pre-game warm ups or sports activity. Some of the possible benefits:
AFTER A HARD WORKOUT or GAME: Using PEPSOM SPORTS® for a hot soak or in the shower will begin to soothe away your hard-earned aches and pains. Some of the possible benefits:
100% Satisfaction guaranteed or your money back.
Distributed by:
The Pepsom Group, Inc. Miami, FL 33137
© The Pepsom Group, Inc. Miami, FL 33137
THE NBATA Mark is a trademark of the NBATA and is being used by The Pepcom Group, Inc. under license from NBATA
Learn more about them at:
www.nbata.com
Visit us at:
www.pepsomsports.com or
www.pepsom.com
| Class | Version | Type | Effective |
|---|---|---|---|
| MAGNESIUM CATION Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51619-400-41 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d392-621f-e053-dbdaa90a74ad | Pepsom Sports Magnesium Sulfate U.S.P. + Mint Drug Facts |
| 51619-400-43 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d392-621f-e053-dbdaa90a74ad | Pepsom Sports Magnesium Sulfate U.S.P. + Mint Drug Facts |
| 51619-400-45 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-d392-621f-e053-dbdaa90a74ad | Pepsom Sports Magnesium Sulfate U.S.P. + Mint Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51619-400-41 | PEPSOM SPORTS SPEARMINT | .454 kg in 1 BAG | FOR SOLUTION | .454 | 2 | |
| 51619-400-43 | PEPSOM SPORTS SPEARMINT | 1.36 kg in 1 BAG | FOR SOLUTION | 1.36 | 2 | |
| 51619-400-45 | PEPSOM SPORTS SPEARMINT | 2.27 kg in 1 BAG | FOR SOLUTION | 2.27 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Magnesium Sulfate, Unspecified | ACTIVE INGREDIENT | DE08037SAB | 2 | |
| Magnesium Cation | ACTIVE MOIETY | T6V3LHY838 | 2 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| Spearmint | INACTIVE INGREDIENT | J7I2T6IV1N | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51619-400 | 51619-400-41, 51619-400-43, 51619-400-45 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Magnesium Sulfate, Unspecified | DE08037SAB | ACTIB |
| Silicon Dioxide | ETJ7Z6XBU4 | IACT |
| Spearmint | J7I2T6IV1N | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 336 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / SUBLINGUAL | 10 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING / ORAL | 68 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION, EXTENDED RELEASE / ORAL | 70 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, LIQUID FILLED / ORAL | 106 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, EXTENDED RELEASE / TRANSDERMAL | 49 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SOLUTION / ORAL | 336 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / ORAL | 300 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / TOPICAL | 6 mg | ||
| Spearmint | SPEARMINT | J7I2T6IV1N | TABLET, ORALLY DISINTEGRATING / ORAL | 0.06 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / NASAL | 20 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUPPOSITORY / RECTAL | 14 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | PELLET / ORAL | 34 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / ORAL | 750 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED / ORAL | 3 mg | ||
| Spearmint | SPEARMINT | J7I2T6IV1N | SOLUTION / ORAL | 0.04 ml/5ml | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION / ORAL | 200 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SUSPENSION / ORAL | 2553 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / RESPIRATORY (INHALATION) | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FOR SUSPENSION / ORAL | 220 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE / ORAL | 5000 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SYSTEM / TRANSDERMAL | 35 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / DENTAL | 19 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / BUCCAL | 3 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 69 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SOLUTION / ORAL | 280 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED PELLETS / ORAL | 69 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SOLUTION / ORAL | 1.8 mg/120ml | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE / ORAL | 1190 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, EXTENDED RELEASE / ORAL | 450 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, SOLUBLE / ORAL | 2 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | DROPS / ORAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 2 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | PASTE / DENTAL | 34 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, DELAYED RELEASE / ORAL | 3.2 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | LOZENGE / ORAL | 120 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE PARTICLES / ORAL | 170 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / VAGINAL | 8 %w/w | ||
| Spearmint | SPEARMINT | J7I2T6IV1N | TABLET / ORAL | 0.09 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CREAM / VAGINAL | 51 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, EXTENDED RELEASE / ORAL | 168 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, DELAYED RELEASE / ORAL | 40 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION / ORAL | 400 mg | ||
| Spearmint | SPEARMINT | J7I2T6IV1N | TABLET, CHEWABLE / ORAL | 2.1 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | INSERT / VAGINAL | 8 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 636a9d7b-1e6d-26a7-308e-02b04e90f703 | 6e63a3ea-71fd-054e-a262-b12e20f75669 | 2010-05-27 | Warnings | 636a9d7b-1e6d-26a7-308e-02b04e90f703 6e63a3ea-71fd-054e-a262-b12e20f75669 |
Adverse event summaries are temporarily unavailable. Other product information remains available.